Mankind Pharma records over 29% YoY growth in Q1 PAT
Mumbai, July 30 -- Domestic revenue (ex-Consumer Health) increased 11.0% YoY to Rs 3,180 crore, driven primarily by double digit growth in Mankind business and supported by strong growth in BSV specialty business.
The Consumer Healthcare Business has recorded revenue of Rs 246 crore (up 4% YoY), partly impacted by base effect of discontinued cash and carry business.
Revenue from International business increased by 29% YoY to Rs 605 crore in Q1FY27.
EBITDA improved by 24.7% YoY to Rs 1,060 crore while EBITDA margin expanded 250 basis points YoY to 26.3%
Profit before tax in Q1 FY27 stood at Rs 769 crore, up by 42% from Rs 540 crore in Q1 FY26.
"Our disciplined execution and strengthening business fundamentals, resulted in improvements...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.